Biotech key to Russia’s industrial sovereignty – Putin
President Putin emphasizes the strategic importance of biotechnology supported by AI for Russia's industrial sovereignty during the Future Technologies Forum in Moscow.
An executive and a magnate: Bioceres is embroiled in a legal battle with a pending bankruptcy request
Bioceres, a prominent biotech unicorn in Argentina, is now facing a legal dispute over management between its shareholders, resulting in a bankruptcy filing.
China’s biotech boom sends price of lab monkeys for drug tests climbing
The prices of laboratory monkeys in China for drug testing have surged dramatically, exceeding the average annual salary in the country.
Songdo International City’s Biopharmaceutical Production Capacity Surpasses 1 Million Liters Annually
The annual production capacity of biopharmaceuticals in Songdo International City has exceeded 1 million liters, marking significant growth due to new factories.
Capital injection: China backs AI drug makers in self-reliance drive
The Chinese government is significantly investing in AI drug manufacturers to foster self-reliance in the biotech sector, exemplified by METiS TechBio's success in funding and drug development.
8 dead in biotech workshop blast in central China
A blast at a biotechnology factory in Shanxi province, China, has resulted in eight fatalities and an investigation into the incident is underway.
Game-changing nose spray promises to stop flu in its tracks
Researchers developed a novel nasal spray loaded with antibodies that has shown potential to block flu infection in early tests on animals and humans.
How innovation is born at CES 2026: seven startups looking to the future
CES 2026 showcases innovative startups like BTRY, CytoAurora Biotech, and others, each pushing the boundaries of technology and sustainability.
The ‘biology winter’ thaws: why investors are piling into Hong Kong’s biotech IPOs
Investors are increasingly supporting biotech IPOs in Hong Kong due to a resurgence in licensing deals and positive post-IPO performance, driving expectations of continued momentum through 2026.